Health Delivery Research Landscape (2009)

An overview of New Zealand research capability focused on health delivery  - 60 pages, published in March 2009.

Contents

Summary

All health research plays a role, directly or indirectly, in supporting improvements and innovation in health services.  Health delivery research can be identified as that sub-set of health research with a primary objective of directly improving people’s health through the application of knowledge and/or improving the effectiveness and efficiency of health and disability services. 

The amount and nature of health delivery research in New Zealand is currently poorly understood.  This landscape report addresses this gap.  It compiles information from a range of existing sources and includes an analysis of Health Research Council (HRC) funding contract data.  Key findings are that:

  • Total health delivery research for 2007/08 is estimated at $38 million, around 27% of total health-related R&D funded by government.  This estimate should be regarded as indicative only and is likely to be an underestimate. 
  • The HRC funds around two-thirds of health delivery research, with Ministry of Health (MoH) and District Health Boards (DHBs) also significant funders.  In 2007/08, the HRC funded $21 million of health delivery research; 32% of their total health research investment for that year.  Public sector agencies, including MoH and DHBs, funded a further $17 million. 
  • Most health research is done in universities, with these organisations and other tertiary institutes undertaking a reported $124 million of health-related R&D in 2006; 46% of total health-related R&D across government, higher education and business sectors. 
  • In 2007, 982 applications for human health research were approved by New Zealand regional health ethics committees.  Of these, 144 were for trials sponsored by a pharmaceutical or medical device company, 404 were for clinical trials funded from other sources, and 434 were for clinical and non-clinical research other than trials. 
  • Clinical academics make up 21% of the HRC-funded research workforce and are the fastest growing health research workforce category.  Full-time equivalents (FTEs) in this area are still small at 36 (compared with 391 overall), but numbers of individuals are much higher at 273, reflecting their main roles as clinicians. 

Skip to:

Summary | Sections 2-4 | Section 5 | Section 6 | Sections 7-9 | Annexes 1-2


About Attachments...

Page updated 23 Mar 2009